Phantom Earthquake Syndrome is a rare condition experienced by individuals who have survived significant earthquakes, characterized by false sensations of ground movement and symptoms such as dizziness, anxiety, and nausea. Patients often face …
Mal de Débarquement Syndrome (MdDS) is a debilitating condition characterized by persistent sensations of movement after disembarking from transport, affecting daily activities and quality of life. Symptoms vary among individuals and typically …
The article discusses the crucial role of microglia, the central nervous system’s immune cells, in the development of the dopaminergic system, which is vital for reward processing and motor control. Microglia undergo significant changes during …
The article discusses the neuroprotective effects of Salvia aristata, particularly its potential in treating cognitive impairments related to neurodegenerative diseases like Alzheimer’s. Salvia aristata extracts have demonstrated the ability to …
Salvia aristata, a medicinal herb known for enhancing cognitive function, exhibits significant neuroprotective effects against oxidative stress and neuroinflammation, which are key factors in Alzheimer’s disease. Recent studies show that its …
N-Acetylcysteine (NAC) is an antioxidant that shows potential in treating Alzheimer’s disease (AD) by replenishing glutathione levels in the brain. Alzheimer’s is marked by cognitive decline, memory loss, and amyloid-beta (Aβ) plaque …
The article emphasizes the critical importance of timely and accurate diagnosis for Parkinson’s disease (PD) to ensure effective management and treatment. Due to the lack of definitive diagnostic tests, many patients are diagnosed only after …
The article discusses the role of Traditional Chinese Medicine (TCM) in enhancing mitochondrial health and its potential application in neurodegenerative diseases (NDDs). TCM employs natural compounds and herbal formulas that improve mitochondrial …
The article discusses the growing concern of cognitive impairments, particularly Alzheimer’s disease (AD), in the aging global population. Mild cognitive impairment (MCI) serves as a critical stage before dementia, where early intervention is …
The article discusses Parkinson’s disease (PD), a neurodegenerative disorder marked by motor impairments and the loss of dopaminergic neurons. Traditional treatments primarily alleviate symptoms without halting progression. Recent studies …
The article discusses the key features and applications of nonvolatile memristive devices, which are distinct from traditional memory components due to their ability to change resistance based on historical voltage and current. Key features include …
Ginsenoside Rd (GSRd) is a bioactive compound derived from ginseng, showing potential in treating various neurological disorders such as ischemic stroke, spinal cord injury (SCI), Alzheimer’s disease (AD), and Parkinson’s disease (PD). In …
The article provides an overview of Alzheimer’s Disease (AD), a neurodegenerative disorder marked by cognitive decline and memory loss, primarily affecting the elderly. It emphasizes the role of biomarkers—specifically amyloid, tau, and …
The article examines the significant interactions between tau protein and the heterogeneous nuclear ribonucleoprotein (hnRNP) family, emphasizing their role in neurodegenerative diseases, particularly Alzheimer’s disease (AD). Tau, known for …
The article discusses the critical role of immune modulation in the treatment of Alzheimer’s disease (AD), highlighting how neuroinflammation and immune dysfunction contribute to AD progression. Microglia, the brain’s immune cells, can …
Recent advancements in synaptic PET imaging techniques have transformed dementia diagnosis by enabling the assessment of synaptic integrity, which is more directly linked to cognitive impairment than traditional methods that focus on amyloid plaques …
The article discusses the role of TDP-43 (TAR DNA-binding protein 43) and its SUMOylation in neurodegenerative diseases like Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD). TDP-43 mislocalization and cytoplasmic aggregation are …
Visual working memory (VWM) is a vital cognitive function for storing and manipulating visual information, significantly impacted by aging and conditions like amnestic mild cognitive impairment (aMCI), a precursor to Alzheimer’s disease. As VWM …
Protein palmitoylation is a critical post-translational modification in which palmitate attaches to cysteine residues in proteins, influencing their function, localization, and interactions essential for neuronal health. It plays a significant role …
Alzheimer’s disease (AD) is a progressive neurodegenerative disorder leading to cognitive decline and is the most prevalent cause of dementia. Key pathological features include amyloid-beta plaques and tau protein tangles in the brain. …
Psilocybin, a natural compound found in certain mushrooms, is being studied for its therapeutic potential in mental health and neurodegenerative diseases, notably major depression and dementia. Research suggests that psilocybin promotes …
Recent bioinformatics analyses have identified 612 differentially expressed genes (DEGs) in Alzheimer’s Disease (AD) from the GSE138260 dataset, with 388 upregulated genes primarily related to sensory perception and 224 downregulated genes …
The article discusses Parkinson’s Disease and Huntington’s Disease, highlighting their symptoms, progression, causes, prognosis, treatment options, and differences. Parkinson’s Disease primarily affects individuals over 60, …
The article discusses freezing of gait, a common symptom of Parkinson’s disease characterized by a brief, involuntary inability to move, often described as feeling like feet are “glued” to the ground. While it can occur at any …
Parkinson’s disease (PD) is a progressive neurological disorder resulting from the degeneration of dopamine-producing neurons, leading to motor symptoms such as tremors, slowness of movement, rigidity, and balance issues. Non-motor symptoms …
The article discusses the relationship between olfactory dysfunction and Parkinson’s Disease (PD), highlighting that impaired smell can be an early indicator of the disease. Parkinson’s affects about 1% of the global population over 60, with …
Tardive dyskinesia (TD) is a neurological disorder primarily caused by long-term use of dopamine receptor antagonists, particularly first-generation antipsychotic medications, affecting at least 20% of users. Symptoms include involuntary movements …
Tardive dyskinesia (TD) is a neurological disorder marked by involuntary muscle movements, primarily resulting from long-term use of antipsychotic medications. Symptoms often include repetitive movements of the face, limbs, and trunk, which can lead …
Tardive dyskinesia (TD) is a neurological disorder often resulting from long-term use of antipsychotic medications, commonly prescribed for mental health conditions like schizophrenia and bipolar disorder. Symptoms include repetitive muscle movements …
The article discusses movement disorders, highlighting the differences between hyperkinetic disorders, such as tardive dyskinesia (TD), and hypokinetic disorders, such as Parkinson’s disease. Tardive dyskinesia is characterized by involuntary …
Tardive dyskinesia (TD) is a neurological disorder marked by involuntary, repetitive movements, often resulting from long-term use of antipsychotic medications that block dopamine receptors. Symptoms typically appear after prolonged medication use …
Tardive dyskinesia (TD) is a neurological syndrome marked by involuntary movements, often resulting from long-term use of medications, particularly antipsychotics. Symptoms can appear years after starting treatment and may include lip-smacking, …
Aduhelm (aducanumab) is a monoclonal antibody specifically designed to target beta-amyloid plaques in the brains of individuals with Alzheimer’s Disease (AD), with the aim of slowing disease progression. Unlike traditional treatments that focus …
Alzheimer’s disease, the most prevalent form of dementia, accounts for 60% to 80% of cases and is characterized by the buildup of amyloid plaques and tau tangles in the brain, leading to progressive cognitive decline. Unlike normal age-related …
The article discusses the connection between HIV and neurocognitive disorders, particularly focusing on HIV-associated Neurocognitive Disorders (HAND) and HIV-associated dementia (HAD). It highlights how HIV infiltrates the brain early in the …
The article provides a comparative overview of Parkinson’s Disease and Amyotrophic Lateral Sclerosis (ALS), highlighting key differences in symptoms, progression, underlying causes, and treatment approaches. Parkinson’s Disease is a …
The article provides an overview of Parkinson’s disease (PD), a progressive neurological disorder characterized by the degeneration of dopamine-producing neurons, leading to various motor and non-motor symptoms. Key motor symptoms include …
Parkinson’s disease (PD) is a progressive neurodegenerative disorder primarily affecting movement due to the loss of dopamine-producing neurons. With approximately 153,000 individuals in the UK living with PD, it is the fastest-growing …
The article discusses the significance of the SAGE test in the early detection of dementia, highlighting its role in identifying cognitive decline through a user-friendly self-assessment that takes about 15-20 minutes to complete. Developed by …
Alzheimer’s disease (AD) is a progressive neurodegenerative disorder that leads to cognitive decline, memory loss, and behavioral changes. Symptoms often start with subtle memory lapses and progress to difficulties in planning and familiar …
Alzheimer’s disease is a progressive neurodegenerative disorder that primarily affects memory, thinking, and behavior, accounting for 60-80% of dementia cases. Early symptoms include forgetfulness, which disrupts daily activities and personal …
The article distinguishes between amnesia and dementia, both of which involve memory loss but differ in their nature and implications. Amnesia is a specific memory loss often due to brain injury, trauma, or psychological factors, categorized into …
Multi-infarct dementia is a cognitive decline condition caused by multiple small strokes, known as transient ischemic attacks (TIAs), leading to cumulative brain damage. Each TIA results in localized brain tissue death, which can ultimately impair …
Vascular dementia is a prevalent form of dementia caused by reduced blood flow to the brain, leading to cognitive decline due to damaged brain tissue. It commonly arises from conditions that harm blood vessels, such as strokes, high blood pressure, …
The article “Understanding Alzheimer’s: What You Need to Know About the Disease” provides an overview of Alzheimer’s disease, highlighting its key features such as memory loss, confusion, and behavioral changes. It notes that …
The article “Understanding Alzheimer’s Disease: Causes, Symptoms, and Risk Factors” provides an overview of Alzheimer’s disease, a neurodegenerative condition marked by cognitive decline and memory loss due to abnormal protein …
Parkinson’s disease (PD) is a progressive neurodegenerative disorder that primarily affects movement due to the loss of dopamine-producing neurons in the brain. Symptoms develop gradually and include tremors, bradykinesia, rigidity, postural …
The article discusses the key symptoms and characteristics of mixed dementia, which is a combination of Alzheimer’s disease and vascular dementia, making diagnosis challenging due to overlapping symptoms. Common signs include memory loss, …
The article discusses the essential roles of gray and white matter in cognitive function. Gray matter, composed of neuronal cell bodies and unmyelinated axons, is crucial for processing information, memory formation, motor control, and emotional …
Balance disorders are conditions that impair a person’s ability to maintain equilibrium, leading to symptoms like dizziness, vertigo, and unsteadiness. Key causes include inner ear disorders (e.g., BPPV), neurological conditions (e.g., …
The article provides a comprehensive overview of Alzheimer’s disease, detailing its symptoms, stages, and impact on daily life. Key early symptoms include memory loss, difficulties with problem-solving, and challenges in completing familiar …
The article discusses the complexity of vascular dementia, highlighting its varied symptoms such as memory loss, confusion, impaired judgment, mood changes, and difficulty with daily tasks. These symptoms often interfere with daily life and can …
